Takis S.r.l
Rome, Lazio, Italy · Biopharma, Biotechnology, Health Care
Takis S.r.l. is a biopharmaceutical company focused on developing innovative therapies and diagnostics for cancer treatment. They specialize in antibody-based therapies and have a strong commitment to advancing cancer research. Their groundbreaking projects aim to improve patient outcomes through targeted approaches.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Rome, Lazio, Italy
- Employees
- 49
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- takisbiotech.com
- Company page
Recent activity at Takis S.r.l
- : Takis S.r.l. partners with Sapienza University and Tethis to enhance HER3-targeted therapies for lung cancer. (date Fundz recorded it)
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
About Takis S.r.l: questions and answers
What does Takis S.r.l do?
Takis S.r.l. is a biopharmaceutical company focused on developing innovative therapies and diagnostics for cancer treatment. They specialize in antibody-based therapies and have a strong commitment to advancing cancer research. Their groundbreaking projects aim to improve patient outcomes through targeted approaches.
Where is Takis S.r.l headquartered?
Takis S.r.l is headquartered in Rome, Lazio, Italy.
How many employees does Takis S.r.l have?
Takis S.r.l has about 49 employees.
What is the latest news on Takis S.r.l?
On Oct 3, 2025, Takis S.r.l. partners with Sapienza University and Tethis to enhance HER3-targeted therapies for lung cancer.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy